Roses (Rosa rugosa) are a famous flower with high ornamental and economic value. But the petals of roses are usually pink and purple, which restricted its application in garden settings. Flavonols and anthocyanins are crucial secondary metabolites related to flower pigmentation in plants. While MYB transcription factors involved in the biosynthesis pathway of anthocyanins have been identified in roses, the functional characterization of the MYB transcription factor regulating flavonol synthesis in R. rugosa remains unexplored. In this study, we isolated and characterized the R2R3-MYB transcription factors RrMYB12 and RrMYB111 involved in regulation of the flavonol biosynthetic pathway from R. rugosa. The bioinformatics analysis indicated that both the RrMYB12 and RrMYB111 belong to the R2R3-MYB subgroup 7 family. qRT-PCR analysis showed that RrMYB12 and RrMYB111 were expressed at low levels in roots and flowers. And transactivation activity assay indicated that RrMYB12 and RrMYB111 were transcriptional activators. The overexpression of RrMYB12 and RrMYB111 in tobacco resulted in an elevation of flavonol levels and a reduction in anthocyanin levels in flowers due to the upregulation of structural genes involved in flavonol synthesis, while the biosynthesis genes for the anthocyanin pathway were significantly downregulated. The transient reporter assay demonstrated that RrMYB12 exhibited strong activation of the promoters of RrCHS and RrFLS in Nicotiana benthamiana leaves following transient transformation. Furthermore, it was observed that RrMYBs displayed binding specificity to the promoter region of CsFLS.The functional characterization of the flavonol synthesis regulatory factors RrMYB12 and RrMYB111 offers a deeper understanding of the regulatory mechanism governing flavonol biosynthesis in roses, while also presenting an effective tool for genetic manipulation aimed at creating new varieties.

Apple pectin (AP), a well-established dietary fiber, offers significant health benefits, particularly in immunomodulation. However, the structure-activity relationship (SAR) in this context remains poorly understood. This study aimed to elucidate the impact of varying degrees of esterification (DE) on AP's SAR in immunomodulatory activity. AP-Es (AP-E1, AP-E2, AP-E3) with different DE were prepared using mild ultrasound-assisted alkali de-esterification, followed by SAR analysis. Results revealed that AP-E3, with the lowest DE (5.08 ± 0.22 %), demonstrated a significant reduction in homogalacturonan (HG) domains and a corresponding increase in rhamnogalacturonan-I (RG-I) domains, which coincided with enhanced immunomodulatory effects. The molecular weights of AP-E1, AP-E2, and AP-E3 were determined to be 30.94 ± 0.83 kDa, 27.61 ± 0.65 kDa, and 22.17 ± 0.57 kDa, respectively. To further explore the underlying mechanism, transgenic zebrafish with fluorescent macrophages were utilized. A positive correlation was observed between AP-E3 concentration and the number of fluorescent microspheres engulfed by macrophages. Additionally, AP-E3 significantly upregulated the expression of key immune response genes (tnf-α, il-1β, il-6, cox-2, inos, and nf-κb) and restored the gut microbiota composition and abundance in chloramphenicol-induced immunocompromised zebrafish. Metabolomics analysis revealed that AP-E3 effectively restored metabolic homeostasis by activating multiple signaling pathways associated with signal transduction, immune regulation, and metabolism. These findings highlight the potential of low-esterified AP enriched with RG-I domains as a promising candidate for applications in immune modulation and gut health management.

Our review systematically outlines the bioactivity and industrial applications of key functional compounds in roses, with a particular focus on their potential in food and pharmaceutical industries from technical, economic, and commercialization perspectives. We summarize the evidence supporting the efficacy of rose-derived polyphenols, flavonoids, and essential oils in areas including antioxidant, anti-inflammatory, antibacterial, and neuroprotective effects, which provide a scientific basis for their use in functional foods and preventive medicines. We further evaluated the commercial viability of processing rose by-products. Additionally, we analyze current and potential applications of rose bioactive compounds in natural food preservatives, functional dietary supplements, herbal medicines, and cosmetic products. Finally, we discuss the remaining challenges and future directions for the industrial utilization of roses, including standardization, efficacy validation in humans, and scalable economic models, to facilitate the transition from experimental research to commercially sustainable applications.

Rosa damascena and Rosa rugosa, which are the two most commercial species in the Rosa genus, are used to make rose oil, cosmetics, and functional foods. The majority of polysaccharide constituents of both species is structurally diverse and demonstrates promising biological activities, such as moisturizing, immunomodulation, and antioxidant activity. The extraction technique has a significant impact on the yield, purity, and bioactivity of polysaccharides. Traditional extraction methods (hot water, ethanol) are simple and economical, yet they typically produce low yields and degrade sensitive compounds. Novel extraction methods (pressurized liquid extraction, enzyme-assisted extraction, ultrasound-assisted extraction, microwave-assisted extraction, supercritical fluid extraction) offer higher efficiency, selectivity, and sustainability, while better preserving polysaccharide structure and bioactivity. This review serves as a comparative summary of conventional versus novel extraction methodologies of polysaccharides from R. damascena and R. rugosa, with particular consideration towards the yield, polysaccharide structural integrity, sustainability, and industrial conduct of each methodology. In addition, it summarizes the distribution and functional role of selected polysaccharides in the various organs of the plants, while also providing an overview of their antioxidant mechanisms and potential bioactive applications in health. Challenges and critical factors that surround specific species, standards for processes, and extraction methods, and that therefore appeal to time and economic considerations, are identified. In efforts to optimize the extraction methodology, the high economic and functional potential of the Rosa species can be maximized in the interest of healthy, functional consumables for the pharmaceutical, nutraceutical, and cosmetic industries.